Patents by Inventor Frank Boschelli

Frank Boschelli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML)
    Patent number: 7919625
    Abstract: Compounds of the formula: wherein: n is an integer from 1-3; X is N, CH, provided that when X is N, n is 2 or 3; R is alkyl of 1 to 3 carbon atoms; R1 is 2,4-diCl, 5-OMe; 2,4-diCl; 3,4,5-tri-OMe; 2-Cl, 5-OMe; 2-Me, 5-OMe; 2,4-di-Me; 2,4-diMe-5-OMe, 2,4-diCl, 5-OEt; R2 is alkyl of 1 to 2 carbon atoms, and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: June 16, 2008
    Date of Patent: April 5, 2011
    Assignee: Wyeth LLC
    Inventors: Frank Boschelli, Jennifer M. Golas, Kim T. Arndt
  • 4-ANILINO-3-QUINOLINECARBONITRILES FOR THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML)
    Publication number: 20100029677
    Abstract: Compounds of the formula: wherein: n is an integer from 1-3; X is N, CH, provided that when X is N, n is 2 or 3; R is alkyl of 1 to 3 carbon atoms; R1 is 2,4-diCl, 5-OMe; 2,4-diCl; 3,4,5-tri-OMe; 2-Cl, 5-OMe; 2-Me, 5-OMe; 2,4-di-Me; 2,4-diMe-5-OMe, 2,4-diCl, 5-OEt; R2 is alkyl of 1 to 2 carbon atoms, and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 16, 2008
    Publication date: February 4, 2010
    Applicant: Wyeth
    Inventors: Frank Boschelli, Kim T. Arndt, Jennifer M. Golas
  • 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML)
    Patent number: 7417148
    Abstract: Compounds of the formula: wherein: n is an integer from 1-3; X is N, CH, provided that when X is N, n is 2 or 3; R is alkyl of 1 to 3 carbon atoms; R1 is 2,4-diCl, 5-OMe; 2,4-diCl; 3,4,5-tri-OMe; 2-Cl, 5-OMe; 2-Me, 5-OMe; 2,4-di-Me; 2,4-diMe-5-OMe, 2,4-diCl, 5-OEt; R2 is alkyl of 1 to 2 carbon atoms, and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: November 3, 2004
    Date of Patent: August 26, 2008
    Assignee: Wyeth
    Inventors: Frank Boschelli, Kim T. Arndt, Jennifer M. Golas
  • 4-Anilino-3-quinolinecarbonitriles for the treatment of acute myelogenous leukemia (AML)
    Publication number: 20080119463
    Abstract: The claimed invention is directed to a method of treating, inhibiting, or preventing acute myelogenous leukemia, also called acute myeloid leukemia (AML), using 4-anilino-3-quinolinecarbonitriles.
    Type: Application
    Filed: November 14, 2007
    Publication date: May 22, 2008
    Applicant: Wyeth
    Inventor: Frank Boschelli
  • 4-Anilino-3-quinolinecarbonitriles for the treatment of cancer
    Publication number: 20070010527
    Abstract: The present invention is directed to a method of preventing treating and/or inhibiting cancer using compounds of formula (I): or a pharmaceutically acceptable salt thereof This invention is also directed to pharmaceutical compositions containing compounds of formula (I).
    Type: Application
    Filed: June 22, 2006
    Publication date: January 11, 2007
    Inventor: Frank Boschelli
  • 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (CML)
    Publication number: 20050101780
    Abstract: Compounds of the formula: wherein: n is an integer from 1-3; X is N, CH, provided that when X is N, n is 2 or 3; R is alkyl of 1 to 3 carbon atoms; R1 is 2,4-diCl, 5-OMe; 2,4-diCl; 3,4,5-tri-OMe; 2-Cl, 5-OMe; 2-Me, 5-OMe; 2,4-di-Me; 2,4-diMe-5-OMe, 2,4-diCl, 5-OEt; R2 is alkyl of 1 to 2 carbon atoms, and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: November 3, 2004
    Publication date: May 12, 2005
    Applicant: Wyeth
    Inventors: Frank Boschelli, Kim Arndt, Jennifer Golas